Traumatic Brain Injury Clinical Trial
Official title:
Improving Balance in TBI Using a Low-Cost Customized Virtual Reality Rehabilitation Tool
This research study evaluates the effectiveness of a low-cost Virtual Reality-based (VR) training system in providing a customized balance treatment in a skilled clinical setting. Participants will be assigned to one of three treatment groups.
Status | Recruiting |
Enrollment | 180 |
Est. completion date | October 2018 |
Est. primary completion date | October 2018 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Have been diagnosed with a mild to severe Traumatic Brain Injury (TBI). My TBI severity will be categorized by research study staff based on length of loss of consciousness (LOC), alteration of consciousness/mental state (AOC) or post-traumatic amnesia (PTA). - Must be out of PTA, as indicated by O-log score of > 24 on 2 consecutive days as determined by study staff. - Be at least 3 months post injury. - Speak English. - As determined by study personnel, have at least 20/60 acuity in worst eye according to the Snellen Eye Exam. - As determined by study personnel, receive an acceptable score on the Token Test. - Balance dysfunction as determined by impairment on standing balance measures (Sensory Organization Test) - Be able and willing to comply with study procedures, including follow-up requirements. - Be willing and able to give informed consent Exclusion Criteria: - Have an unstable or uncontrolled seizure disorder. - Have a diagnosis of excessive fluid surrounding my brain. - Have severe cardiac disease (e.g. heart attack or heart failure). - Have uncontrolled or unstable orthostatic hypotension (blood pressure drops suddenly when one stands, causing one to feel light headed or dizzy). - Have had a lower limb injury in the past 90 days. - Have any other injury that affects one's ability to balance. - Have a pre-existing condition that significantly affects one's alignment or function of one's lower limb while standing. - Be on any medication that may affect one's balance, strength, or muscle coordination (e.g. Botox, Baclofen). - Have significant neurological history (e.g.epilepsy that began before TBI, multiple sclerosis) other than TBI. - Have significant psychiatric history (i.e. schizophrenia). - Have a history of significant drug abuse. - Have had physical or occupational therapy or treatment for balance disorder in the past 30 days. - Have difficulty following or responding to commands that would limit study participation. - Be currently enrolled in another research study that is likely to affect participation in this research study. - Have any underlying medical conditions that would limit study participation. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Kessler Foundation | West Orange | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Kessler Foundation | Fort Belvoir Community Hospital, Kessler Institute for Rehabilitation, University of Southern California, VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Balance Assessment | Physical tasks scored based on performance, e.g., 10 Meter walk, Balance Tasks and Computerized Sensory Organization Test | 4 months | No |
Secondary | Global Functioning evaluating the impact of the intervention on everyday life | Questionnaires | 4 months | No |
Secondary | Neuropsychological Assessment examining changes in cognitive functioning | Questionnaires | 4 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT05503316 -
The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System
|
N/A | |
Completed |
NCT04356963 -
Adjunct VR Pain Management in Acute Brain Injury
|
N/A | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Terminated |
NCT03698747 -
Myelin Imaging in Concussed High School Football Players
|
||
Recruiting |
NCT05130658 -
Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training
|
N/A | |
Recruiting |
NCT04560946 -
Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI
|
N/A | |
Completed |
NCT05160194 -
Gaining Real-Life Skills Over the Web
|
N/A | |
Recruiting |
NCT02059941 -
Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines
|
N/A | |
Recruiting |
NCT03940443 -
Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
|
||
Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
Completed |
NCT04465019 -
Exoskeleton Rehabilitation on TBI
|
||
Recruiting |
NCT04530955 -
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)
|
N/A | |
Recruiting |
NCT03899532 -
Remote Ischemic Conditioning in Traumatic Brain Injury
|
N/A | |
Suspended |
NCT04244058 -
Changes in Glutamatergic Neurotransmission of Severe TBI Patients
|
Early Phase 1 | |
Completed |
NCT03307070 -
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
|
N/A | |
Recruiting |
NCT04274777 -
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
|
||
Withdrawn |
NCT04199130 -
Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI
|
N/A | |
Withdrawn |
NCT05062148 -
Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery
|
N/A | |
Withdrawn |
NCT03626727 -
Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
|
Early Phase 1 |